{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:27:23Z","timestamp":1788200843272,"version":"build-2803163510"},"reference-count":30,"publisher":"BMJ","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2010,9,17]]},"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Differentiation between multicentric Castleman's disease and systemic immunoglobulin (Ig) G4-related lymphadenopathy is sometimes difficult. It has been suggested that measurement of the IgG4-\/IgG-positive cell ratio is useful for the differential diagnosis of the two diseases. However, the authors present a detailed report of six patients with multicentric Castleman's disease with abundant IgG4-positive cells (IgG4-\/IgG-positive cell ratio, &gt;40%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the present series, the patients showed systemic lymphadenopathy, polyclonal hypergammaglobulinaemia and elevated serum interleukin-6 (IL-6) and C-reactive protein levels. Further, anaemia, hypoalbuminaemia, hypocholesterolaemia and thrombocytosis were observed. These findings were consistent with those of multicentric Castleman's disease. Although five patients showed elevated serum IgG4 levels, only two patients showed an increased serum IgG4\/IgG ratio. However, the two patients showed highly elevated serum IgG4 levels, but the serum IgG4\/IgG ratios were, although increased, not very high. Also, a patient with increased serum IgG4\/IgG ratio showed a good response to antihuman IL-6 receptor monoclonal antibody (tocilizumab). Histologically, the germinal centres were mostly small and regressive, and frequently penetrated by hyalinised blood vessels, and there was no eosinophil infiltration. These findings were different from those of IgG4-related lymphadenopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The authors conclude that multicentric Castleman's disease sometimes occurs with abundant IgG4-positive cells and elevated serum IgG4 levels. Therefore, the two diseases cannot be differentially diagnosed by immunohistochemical staining alone. Laboratory findings, especially IL-6 level, C-reactive protein level and platelet count, are important for the differential diagnosis of the two diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jcp.2010.082958","type":"journal-article","created":{"date-parts":[[2010,10,25]],"date-time":"2010-10-25T21:55:55Z","timestamp":1288043755000},"page":"1084-1089","source":"Crossref","is-referenced-by-count":118,"title":["Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases"],"prefix":"10.1136","volume":"63","author":[{"given":"Yasuharu","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Morito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohichi","family":"Mizobuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Iwao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2010,10,24]]},"reference":[{"key":"2025120519280195000_63.12.1084.1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4"},{"key":"2025120519280195000_63.12.1084.2","first-page":"119","article-title":"Benign giant lymphoma: the clinical signs and symptoms","volume":"12","author":"Flendrig","year":"1969","journal-title":"Folia Med Neerl"},{"key":"2025120519280195000_63.12.1084.3","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#"},{"key":"2025120519280195000_63.12.1084.4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.1985.3.9.1202","article-title":"A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients","volume":"3","author":"Frizzera","year":"1985","journal-title":"J Clin Oncol"},{"key":"2025120519280195000_63.12.1084.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4602"},{"key":"2025120519280195000_63.12.1084.6","doi-asserted-by":"publisher","DOI":"10.1177\/106689690401200104"},{"key":"2025120519280195000_63.12.1084.7","doi-asserted-by":"publisher","DOI":"10.1177\/1066896908315812"},{"key":"2025120519280195000_63.12.1084.8","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.17"},{"key":"2025120519280195000_63.12.1084.9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318157c068"},{"key":"2025120519280195000_63.12.1084.10","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.049825"},{"key":"2025120519280195000_63.12.1084.11","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800692"},{"key":"2025120519280195000_63.12.1084.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-006-0158-5"},{"key":"2025120519280195000_63.12.1084.13","doi-asserted-by":"publisher","DOI":"10.1177\/1066896907306969"},{"key":"2025120519280195000_63.12.1084.14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00000478-198304000-00001","article-title":"A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients","volume":"7","author":"Frizzera","year":"1983","journal-title":"Am J Surg Pathol"},{"key":"2025120519280195000_63.12.1084.15","doi-asserted-by":"crossref","unstructured":"Ye B Gao SG Li W . A retrospective study of unicentric and multicentric Castleman's disease: a report of 52 patients. Med Oncol Published Online First: 24 November 2009. doi:10.1007\/s12032-009-9355-0.","DOI":"10.1007\/s12032-009-9355-0"},{"key":"2025120519280195000_63.12.1084.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2010.02524.x"},{"key":"2025120519280195000_63.12.1084.17","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/blood.V74.4.1360.1360","article-title":"Pathogenic significance of interleukin-6 (IL-6\/BSF-2) in Castleman's disease","volume":"74","author":"Yoshizaki","year":"1989","journal-title":"Blood"},{"key":"2025120519280195000_63.12.1084.18","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyp073"},{"key":"2025120519280195000_63.12.1084.19","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.089169"},{"key":"2025120519280195000_63.12.1084.20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/B978-0-08-037378-2.50030-9","article-title":"Interleukin cascade for the regulation of IgA synthesis and immune responses","volume":"36","author":"McGhee","year":"1989","journal-title":"Protides Biol Fluids"},{"key":"2025120519280195000_63.12.1084.21","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4049\/jimmunol.147.5.1557","article-title":"Hydrocortisone and IL-4 induce IgE isotype switching in human B cells","volume":"147","author":"Jabara","year":"1991","journal-title":"J Immunol"},{"key":"2025120519280195000_63.12.1084.22","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3038.1999.00016.x"},{"key":"2025120519280195000_63.12.1084.23","first-page":"278","article-title":"Regulation of human IgG subclass production by cytokines: human IgG subclass production enhanced differentially by interleukin-6","volume":"84","author":"Kawano","year":"1995","journal-title":"Immunology"},{"key":"2025120519280195000_63.12.1084.24","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(90)90074-2"},{"key":"2025120519280195000_63.12.1084.25","first-page":"981","article-title":"Elevated IgG4 levels in a case with multicentric Castleman's disease","volume":"99","author":"Ishida","year":"1997","journal-title":"Br J Haematol"},{"key":"2025120519280195000_63.12.1084.26","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800836"},{"key":"2025120519280195000_63.12.1084.27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21697"},{"key":"2025120519280195000_63.12.1084.28","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.3748\/wjg.v12.i38.6225","article-title":"Pancreatic cancer with a high serum IgG4 concentration","volume":"12","author":"Kamisawa","year":"2006","journal-title":"World J Gastroenterol"},{"key":"2025120519280195000_63.12.1084.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01264.x"},{"key":"2025120519280195000_63.12.1084.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2008.01222.x"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.2010.082958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:28:10Z","timestamp":1764991690000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.2010.082958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,24]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,11,19]]},"published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1136\/jcp.2010.082958"],"URL":"https:\/\/doi.org\/10.1136\/jcp.2010.082958","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,24]]}}}